Literature DB >> 31099285

Managing patients with ibrutinib-resistant CLL: don't stop ibrutinib until you are ready with the next therapy.

Pek Sang Chloe Tang1, Constantine Tam1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31099285     DOI： 10.1080/10428194.2019.1616189

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  1 in total

1.  Disease Flare During Temporary Interruption of Ibrutinib Therapy in Patients with Chronic Lymphocytic Leukemia.

Authors:  Paul J Hampel; Timothy G Call; Kari G Rabe; Wei Ding; Eli Muchtar; Saad S Kenderian; Yucai Wang; Jose F Leis; Thomas E Witzig; Amber B Koehler; Amie L Fonder; Susan M Schwager; Daniel L Van Dyke; Esteban Braggio; Susan L Slager; Neil E Kay; Sameer A Parikh
Journal:  Oncologist       Date:  2020-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.